In this episode, Henry Norton sits down with Mark Tapsak, Chief Science Officer at Glucotrack and one of Dexcom’s earliest employees.

Mark Tapsak left Medtronic for a “crazy startup” called Dexcom after seeing data so compelling he couldn’t say no. Two decades later, he’s back in the CGM game as Chief Science Officer at Glucotrack, working on a 3-year implantable sensor that lives in the bloodstream.